Views & Analysis AMR: How pharma is leading the charge against superbugs GPs being sent warning letters and the World Health Organization’s World Vaccinations Week have brought the spectre of antimicrobial resistance (AMR) back into the headlines of late.
Partner Content Partner Content Superbugs & Superdrugs USA Conference returns to New Jer... Superbugs & Superdrugs USA Conference, Nov 2018
Views & Analysis Medtech is key in fight against AMR Paul Chapman examines the challenge of antimicrobial resistance (AMR) and how it could be beaten.
Partner Content Partner Content AMR research, funding and incentives – updates at SMi event ... SMi reports: Antimicrobial resistance was predicted by Alexander Fleming in his Nobel lecture (1945).
News UK and Russian experts tackle superbugs The AMR Centre is to collaborate with Russia's Skolkovo Foundation
Partner Content Partner Content “SPARKing" New Antibiotic Drug Discovery “SPARKing" New Antibiotic Drug Discovery
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.